Skip to main content

Advertisement

SpringerLink
Log in

Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

In many countries, utility measures are required for allocation decisions. Unlike the EuroQoL-5D (EQ-5D), the dermatology life quality index (DLQI) has not been developed for the derivation of utilities. Purpose of this study was to develop and test an algorithm for the transformation of DLQI scores into utilities. Pre-existing data of two cross-sectional studies (for development, n = 1,511; for cross-validation n = 2,009) of German psoriasis patients were reanalyzed. Both EQ-5D global score and EQ-5D visual analogue scale (VAS) were used as utility measures. Correlations were computed to identify predictors of EQ-5D utilities. Linear stepwise regressions were conducted using DLQI and further possible predictors to find the optimal mapping algorithm. Using only DLQI as predictor resulted in coefficients of determination of r 2 = 0.235 (EQ-5D global score) and r 2 = 0.242 (EQ-5D VAS). In the final algorithm, seven predictors were included which correctly predicted EQ-5D VAS for 60.4 % (development database) and 60.8 % of all patients (cross-validation database) within a range of ±15 units. The algorithm explained 31.3 % of the EQ-5D variance in the development database and 26.8 % in the cross-validation database. In conclusion, mapping of DLQI on EQ-5D in psoriasis patients has severe limitations in validity and clinical relevance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Augustin M, Amon U, Braathen L et al (2004) Empfehlungen zur Erfassung von Lebensqualität in der Dermatologie [Recommendations for the assessment of quality of life in dermatology]. J Dtsch Dermatol Ges 2:802–806

    Article  PubMed  Google Scholar 

  2. Augustin M, Kruger K, Radtke MA et al (2008) Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 216:366–372

    Article  PubMed  CAS  Google Scholar 

  3. Augustin M, Reich K, Reich C et al (2008) Quality of psoriasis care in Germany–results of the national study Psoriasis Health 2007. J Dtsch Dermatol Ges 6:640–645

    Article  PubMed  Google Scholar 

  4. Bakker C, van der Linden S (1995) Health related utility measurement: an introduction. J Rheumatol 22:1197–1199

    PubMed  CAS  Google Scholar 

  5. Currie CJ, Conway P (2007) Evaluation of the association between EQ5D utility and dermatology life quality index (DLQI) score in patients with psoriasis. Value Health 16:A470

    Article  Google Scholar 

  6. Finlay AY, Khan GK (1994) Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210–216

    Article  PubMed  CAS  Google Scholar 

  7. Greiner W (2012) Der EQ-5D der EuroQol-Gruppe In: Gesundheitsökonomische Evaluationen (Schöffski O Graf von der Schulenburg, JM eds). Springer, Berlin, pp 411–422

    Book  Google Scholar 

  8. Greiner W, Weijnen T, Nieuwenhuizen M et al (2003) A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 4:222–231

    Article  PubMed  Google Scholar 

  9. Norlin JM, Steen Carlsson K, Persson U et al (2012) Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients. Br J Dermatol 166:797–802

    Article  PubMed  CAS  Google Scholar 

  10. Schmitt J, Wozel G (2005) The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 210(3):194–199

    Article  PubMed  Google Scholar 

  11. Schulenburg vdJ, Claes C, Greiner W et al (1998) Die deutsche Version des EuroQoL Fragebogen [German version of the EuroQol questionnaire]. Zeitschrift für Gesundheitswissenschaften 11:3–20

    Google Scholar 

  12. The EuroQol Group (1990) Euro Qol—a new facility for the measurement of health related quality of life. Health Policy 16:199–208

    Article  Google Scholar 

  13. US Department of Health and Human Services (2009) Food and Drug Administration (FDA) Guidance for industry—patient-reported outcome measures: use in medical product development to support labeling claims. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed 17 Dec 2012

  14. Zentner A, Velasco-Garrido M, Busse R (2005) Methods for the comparative evaluation of pharmaceuticals. HTA report. GMS Health Technol Assess Doc09 (20051115) German Agency for Health Technology Assessment (DAHTA)

Download references

Acknowledgments

This project has been supported by a research Grant from Janssen-Cilag GmbH, Neuss, Germany.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Institute for Health Services in Dermatology and Nursing (IVDP), German Center for Health Services Research in Dermatology, University Medical Center Hamburg, Martinistraße 52, 20246, Hamburg, Germany

    Christine Blome, Florian C. Beikert, Stephan J. Rustenbach & Matthias Augustin

Authors
  1. Christine Blome
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Florian C. Beikert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephan J. Rustenbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matthias Augustin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthias Augustin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blome, C., Beikert, F.C., Rustenbach, S.J. et al. Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities. Arch Dermatol Res 305, 197–204 (2013). https://doi.org/10.1007/s00403-012-1309-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-012-1309-2

Keywords

Search

Navigation